IGFBP-6 regulates SH2D4A expression to promote breast cancer cell cycle progression in response to progesterone - Top-Institutions - MDSpire

IGFBP-6 regulates SH2D4A expression to promote breast cancer cell cycle progression in response to progesterone

  • By

  • Francisco J. Lariz

  • Diana C. Bautista-Tovar

  • Alejandro Lazo-Loya

  • Kevin D. Houston

  • June 30, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    University of Minnesota
    University of Minnesota

    Minneapolis, MN

    Key Differentiators

    • Oncology

  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Oncology

  • #3

    Seoul National University
    Seoul National University

    Seoul, South Korea

    Key Differentiators

    • Oncology

  • #4

    University of Colorado Denver
    University of Colorado Denver

    Denver, CO

    Key Differentiators

    • Oncology

  • #5

    Joint Newcastle Health Hospitals
    Joint Newcastle Health Hospitals

    Newcastle upon Tyne, UK

    Key Differentiators

    • Oncology

Original Source(s)

IGFBP-6 regulates SH2D4A expression to promote breast cancer cell cycle progression in response to progesterone

  • by Francisco J. Lariz, Diana C. Bautista-Tovar, Alejandro Lazo-Loya, Kevin D. Houston

  • June 30, 2026

Related Content

A synergistic framework integrating global context and structural features for breast ultrasound lesion detection

Case Report: First report of PIK3CA-related overgrowth spectrum revealed by refractory chylorrhea after breast-conserving surgery: failed thoracic-duct ligation

ESMO Breast Cancer 2026 Highlights: SERENA-6

Harold Burstein, MD, PhD, and Erica Mayer, MD, MPH discuss results from the SERENA-6 trial, which were presented at the 2026 ESMO Breast Cancer Congress.

  • June 26, 2026

  • 1 min